查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467728

2024-2032 年按应用、配销通路、给药途径和地区分類的人类生长激素市场报告

Human Growth Hormone Market Report by Application, Distribution Channel, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球人类生长激素市场规模达57亿美元。

HGH 是一种胜肽激素，由脑下垂体产生，可刺激儿童和成人的生长。此激素主要调节细胞的生长、再生、修復、繁殖和代谢，进而促进身体的整体发育。它还调节体液、脂肪代谢以及骨骼和肌肉的生长。 HGH 缺乏会增加疾病和脂肪堆积的风险，而较高水平会导致儿童巨人症和成人肢端肥大症、肌肉萎缩症和短肠症候群。

特纳氏症和其他生长相关疾病的盛行率日益增加是推动市场成长的关键因素之一。特纳氏症是一种主要影响女性的染色体疾病，其特征是 X 染色体完全或部分缺失。生长激素通常用于逆转这种疾病的一些症状，从而增加了全球对 HGH 药物的需求。此外，大众健康意识的增强和对内分泌失调预防措施的认识不断增强，也推动了市场的成长。普瑞德威利症候群 (PWS) 和特发性身材矮小 (ISS) 等多种疾病是由于体内生长激素缺乏引起的，而生长激素可以透过医学合成的 HGH 进行治疗。其他因素，包括健美运动员越来越多地使用 HGH 作为表现增强剂，以及重组人类生长激素 (rHGH) 的开发，预计将进一步推动市场发展。

本报告回答的关键问题

  • 全球人类生长激素市场有多大？
  • 2024-2032年全球人类生长激素市场的预期成长率是多少？
  • 推动全球人类生长激素市场的关键因素是什么？
  • COVID-19 对全球人类生长激素市场有何影响？
  • 根据应用，全球人类生长激素市场的细分如何？
  • 根据配销通路，全球人类生长激素市场的细分如何？
  • 根据给药途径，全球人类生长激素市场的细分如何？
  • 全球人类生长激素市场的关键区域有哪些？
  • 全球人类生长激素市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球人类生长激素市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按应用

  • 生长激素 (GH) 缺乏
    • 市场走向
    • 主要类型
      • 成人生长激素缺乏症
      • 儿童生长激素缺乏症
    • 市场预测
  • 特纳氏症
    • 市场走向
    • 市场预测
  • 特发性身材矮小 (ISS)
    • 市场走向
    • 市场预测
  • 普瑞德威利症候群 (PWS)
    • 市场走向
    • 市场预测
  • 小于胎龄
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药房
    • 市场走向
    • 市场预测
  • 网路药房
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依管理途径

  • 静脉
    • 市场走向
    • 市场预测
  • 肌肉注射
    • 市场走向
    • 市场预测
  • 皮下
    • 市场走向
    • 市场预测
  • 口服
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Eli Lilly and Company
    • EMD Serono Inc.
    • F. Hoffmann-La Roche AG
    • Ferring BV
    • Genentech Inc.
    • Ipsen
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk
    • Pfizer Inc.
    • Sandoz
Product Code: SR112024A2052

The global human growth hormone market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone primarily regulates growth, regeneration, repair, reproduction and metabolism of the cells, thus contributing to the overall development of the body. It also regulates body fluids, fat metabolism and bone and muscle growth. The deficiency of HGH can increase the risk of diseases and fat accumulation, whereas higher levels can cause gigantism in children and acromegaly, muscle-wasting disease and short bowel syndrome in adults.

The increasing prevalence of Turner syndrome and other growth-related disorders is one of the key factors driving the growth of the market. Turner syndrome is a chromosomal disorder that primarily affects females and is characterized by complete or partial loss of X chromosomes. Growth hormones are often administered to reverse some of the symptoms of this disease, thereby increasing the demand for HGH drugs across the globe. Furthermore, increasing health consciousness among the masses and growing awareness regarding the preventive measures against endocrine disorders, are providing a boost to the market growth. Various disorders, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), are caused by the deficiency of growth hormones in the body that can be treated using medically synthesized HGH. Other factors, including a rising utilization of HGH as performance enhancers by bodybuilders, along with the development of recombinant human growth hormone (rHGH), are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human growth hormone market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application, distribution channel and route of administration.

Breakup by Application:

Growth Hormone (GH) Deficiency

Adult GH Deficiency

Pediatric GH Deficiency

Turner Syndrome

Idiopathic Short Stature (ISS)

Prader-Willi Syndrome (PWS)

Small for Gestational Age

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

Breakup by Route of Administration:

Intravenous

Intramuscular

Subcutaneous

Oral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Key Questions Answered in This Report

  • 1. How big is the global human growth hormone market?
  • 2. What is the expected growth rate of the global human growth hormone market during 2024-2032?
  • 3. What are the key factors driving the global human growth hormone market?
  • 4. What has been the impact of COVID-19 on the global human growth hormone market?
  • 5. What is the breakup of the global human growth hormone market based on the application?
  • 6. What is the breakup of the global human growth hormone market based on the distribution channel?
  • 7. What is the breakup of the global human growth hormone market based on the route of administration?
  • 8. What are the key regions in the global human growth hormone market?
  • 9. Who are the key players/companies in the global human growth hormone market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Growth Hormone Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Growth Hormone (GH) Deficiency
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Adult GH Deficiency
      • 6.1.2.2 Pediatric GH Deficiency
    • 6.1.3 Market Forecast
  • 6.2 Turner Syndrome
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Idiopathic Short Stature (ISS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prader-Willi Syndrome (PWS)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Small for Gestational Age
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Subcutaneous
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Eli Lilly and Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 EMD Serono Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Ferring B.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Genentech Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Ipsen
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Novo Nordisk
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sandoz
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Human Growth Hormone Market: Major Drivers and Challenges
  • Figure 2: Global: Human Growth Hormone Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Human Growth Hormone Market: Breakup by Application (in %), 2023
  • Figure 4: Global: Human Growth Hormone Market: Breakup by Distribution Channel (in %), 2023
  • Figure 5: Global: Human Growth Hormone Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Human Growth Hormone Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Human Growth Hormone Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Human Growth Hormone (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Human Growth Hormone (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Human Growth Hormone (Turner Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Human Growth Hormone (Turner Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Human Growth Hormone (Small for Gestational Age) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Human Growth Hormone (Small for Gestational Age) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Human Growth Hormone (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Human Growth Hormone (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Human Growth Hormone (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Human Growth Hormone (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Human Growth Hormone (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Human Growth Hormone (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Human Growth Hormone (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Human Growth Hormone (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Human Growth Hormone (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Human Growth Hormone (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Human Growth Hormone (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Human Growth Hormone (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Human Growth Hormone (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Human Growth Hormone (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Human Growth Hormone (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Human Growth Hormone (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Human Growth Hormone (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Human Growth Hormone (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia Pacific: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia Pacific: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Human Growth Hormone Industry: SWOT Analysis
  • Figure 85: Global: Human Growth Hormone Industry: Value Chain Analysis
  • Figure 86: Global: Human Growth Hormone Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Growth Hormone Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Human Growth Hormone Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Human Growth Hormone Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Human Growth Hormone Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Human Growth Hormone Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Human Growth Hormone Market: Competitive Structure
  • Table 7: Global: Human Growth Hormone Market: Key Players